SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Resmed Inc – ‘8-K’ for 6/11/01

On:  Tuesday, 6/12/01, at 8:24am ET   ·   For:  6/11/01   ·   Accession #:  892569-1-500443   ·   File #:  1-15317

Previous ‘8-K’:  ‘8-K/A’ on 5/1/01 for 2/16/01   ·   Next:  ‘8-K’ on / for 6/15/01   ·   Latest:  ‘8-K’ on / for 4/25/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/12/01  Resmed Inc                        8-K:5,7     6/11/01    2:13K                                    Bowne - Biv/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     14K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML      7K 


8-K   —   Current Report
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Table of Contents
"Item 5. Other Events
"Item 7. Exhibits
"Signature
"Exhibit Index

This is an HTML Document rendered as filed.  [ Alternative Formats ]



  e8-k  

Table of Contents

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported)

June 12, 2001 (June 11, 2001)

 
ResMed Inc.

(Exact name of registrant as specified in its charter)
         
Delaware 0-26308 98-0152841



(State of
Incorporation)
(Commission File Number) (IRS Employer
Identification No.)
 
14040 Danielson Street, Poway, Californa 92064-6857

(Address of principal executive offices) (Zip Code)
 
(858) 746-2400

(Registrant’s telephone number, including area code)
 

(former name or former address, if changed since last report)

 



TABLE OF CONTENTS

Item 5. Other Events.
Item 7. Exhibits.
SIGNATURE
EXHIBIT INDEX
EXHIBIT 99.1


Table of Contents

Item 5. Other Events.

      On June 11, 2001, ResMed Inc. issued a press release pursuant to Rule 135c promulgated under the Securities Act of 1933, as amended, announcing a proposed private placement of $150 million of convertible subordinated notes. However, no assurance can be made that the offering of the notes will be completed.

      A copy of the press release is attached as Exhibit 99.1 to this Form 8-K.

      The notes have not been registered under the Securities Act of 1933 or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act of 1933 and applicable state securities laws. This current report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy the notes.

Item 7. Exhibits.

  99.1   Text of Press Release, dated June 11, 2001.

2



Table of Contents

SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
Dated: June 11, 2001 ResMed Inc.
 
 
 
By:  /s/ WALTER FLICKER

Walter Flicker
Corporate Secretary

3



Table of Contents

EXHIBIT INDEX

  99.1   Text of Press Release, dated June 11, 2001.

4


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on:6/12/01None on these Dates
For Period End:6/11/01
 List all Filings 
Top
Filing Submission 0000892569-01-500443   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 2:21:20.2am ET